23andme sale anne wojcicki ttam.

Anne Wojcicki’s nonprofit, TTAM Research Institute, has received court approval to acquire 23andMe, the genetic testing company she co-founded. The $305 million deal follows 23andMe’s Chapter 11 bankruptcy filing in March and a bidding war with Regeneron Pharmaceuticals. TTAM will take over 23andMe’s DNA testing services, research operations, and telehealth subsidiary. Privacy concerns remain a key issue, with some states opposing the sale due to genetic data protection laws. TTAM has pledged to honor 23andMe’s privacy policies, allowing users to delete their data or opt out of research. The acquisition is expected to close soon.